Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
The AACR and Philadelphia Media Network co-hosted an event in January entitled, “Cancer Precision Medicine: Big Ideas in Research,...
Thursday, Feb. 4 is World Cancer Day, an initiative by the Union for International Cancer Control (UICC) to raise...
Late last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for one of the most...
The AACR strongly aligns with all 69 National Cancer Institute (NCI)-designated centers, which jointly issued a call to action...
We asked experts in cancer precision medicine, immunotherapy, and prevention what breakthroughs we might expect to see in 2016...
The dawning of the new year marked the 75th anniversary of the publication of the first issue of Cancer...
For AACR’s grants program, 2015 was indeed a successful year to reflect upon. Among many highlights, 2015 saw the...
Whether cures for cancer are realized through personalized medicine, cancer vaccines, immunotherapy, or a combination of these or other...
Editor’s Note: Several prominent American Association for Cancer Research (AACR) leaders have shared their reactions to President Obama’s Jan....
The past year brought some progress, which the American Association for Cancer Research highlighted in a guest article for...